Crawford vows ‘transformation’ as FDA commissioner

Share this article:
FDA acting commissioner Lester Crawford told Congress yesterday he plans to lead a transformation of the agency currently under fire for a series of drug safety problems.
"We are going to tap into new technologies and new ways of thinking," Crawford told the Senate Health, Education, Labor and Pensions Committee yesterday as part of his confirmation process to become commissioner. "I am committed to addressing existing concerns regarding post-marketing safety of FDA regulated products."
Crawford is a veterinarian and food policy expert with a doctorate in pharmacology. He has run the FDA since March 2004, when previous commissioner Mark McClellan left to head the Centers for Medicare and Medicaid Services.
President Bush selected Crawford as his pick for FDA commissioner in February.
The committee is expected to vote on his nomination on April 13 and his confirmation is widely expected in a Republican controlled Congress.
Share this article:
You must be a registered member of MMM to post a comment.


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.